Loading...

PE anti-mouse CD150 (SLAM) Antibody

Pricing & Availability
Clone
TC15-12F12.2 (See other available formats)
Regulatory Status
RUO
Other Names
Signaling Lymphocyte Activation Molecule (SLAM), IPO-3
Isotype
Rat IgG2a, λ
Ave. Rating
Submit a Review
Product Citations
publications
TC15-12F12.2
C57BL/6 mouse splenocytes were stained with CD150 (clone TC15-12F12.2) PE (solid line) or rat IgG2a PE isotype control (broken line).
  • TC15-12F12.2
    C57BL/6 mouse splenocytes were stained with CD150 (clone TC15-12F12.2) PE (solid line) or rat IgG2a PE isotype control (broken line).
  • TC15-12F12_PE_2_102110
    C57BL/6 mouse bone marrow cells were stained with CD150 (clone TC15-12F12.2) PE (filled histogram) or rat IgG2a PE isotype control (open histogram) (gated on lymphoid cell population).
See PE spectral data
Cat # Size Price Quantity Check Availability Save
115903 25 µg 84€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
115904 100 µg 215€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD150 is a 75-95 kD member of the immunoglobulin superfamily, also known as SLAM (signaling lymphocyte activation molecule) or IPO-3. CD150, a single chain type I transmembrane molecule, is expressed on thymocytes, T cell subsets, B cells, dendritic cells, and endothelial cells. The expression is upregulated upon activation. CD150 expression has been shown to be maintained on Th1 but not Th2 clones. T regulatory cells express a relatively high level of CD150. Antibodies against CD150 have been shown to augment IFN-γ production by Th1 cells, especially when co-stimulated through the TCR. CD150 associates with the src homology 2-domain-containing protein tyrosine phosphatase SHP-2, and this association is thought to be involved in signal transduction. In combination with CD48, CD150 is a useful marker for hematopoietic stem cell studies.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse SLAM-human IgG1 fusion protein
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD150 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

The TC15-12F12.2 antibody has been reported to enhance the production of IFN-? by Th1 cells stimulated through TCR. Additional reported applications (for the relevant formats) include: immunoprecipitaion17, enhancing IFN-? production by Th1 cells when stimulated with CD31, and inhibiting CD3 induced T cell proliferation6. The Ultra-LEAF™ purified antibody (Endotoxin <0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 115949 & 115950).

Application References

(PubMed link indicates BioLegend citation)
  1. Castro AG, et al. 1999. J. Immunol. 163:5860. (FC, Costim, IP)
  2. Forsberg EC, et al. 2005. PLoS Genet. 1:e28. (FC)
  3. Terrazas LI, et al. 2005. Int. J. Parasitol. 35:1349. (FC)
  4. Cannons JL, et al. 2006. J. Exp. Med. 203:1551. (FC)
  5. Umemoto T, et al. 2006. J. Immunol. 177:7733. (FC)
  6. Jordan MA, et al. 2007. J. Immunol. 178:1618. (FC, Block) PubMed
  7. Jung Y, et al. 2007. Blood 110:82. PubMed
  8. Pimanda JE, et al. 2007. Proc. Natl. Acad. Sci. USA 104:840.
  9. Sugiyama T, et al. 2007. Proc. Natl. Acad. Sci. USA 104:175.
  10. Kim I, et al. 2006. Blood 108:737. PubMed
  11. Ema H, et al. 2006. Nat Protoc. 1:2979. PubMed
  12. Fraser ST, et al. 2007. Blood 109:4616. PubMed
  13. Jung Y, et al. 2008. Stem Cells. 26:2042. Pubmed
  14. Song J, et al. 2010. Blood 115:2592. PubMed
  15. Cridland SO, et al. 2009. Blood Cell. Mol. Dis. 43:149. (FC) PubMed
  16. Morita Y, et al. 2010. J. Exp Med. 207:1173. PubMed
  17. Talaei N, et al. 2015. J. Immunol. 195(10):4623. PubMed
Product Citations
  1. Ganuza M, et al. 2017. Exp Hematol. 10.1016/j.exphem.2017.04.006. PubMed
  2. Mooney C, et al. 2017. International Journal of Molecular Sciences. 10.3390/ijms18051037. PubMed
  3. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  4. Xu C, et al. 2018. Nat Commun. 9:2449. PubMed
  5. Gao B, et al. 2018. Aging Cell. 3. PubMed
  6. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  7. Wang X, et al. 2018. Stem Cell Reports. 11:274. PubMed
  8. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  9. Xia P et al. 2018. Immunity. 48(4):688-701 . PubMed
  10. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  11. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  12. Pinho S et al. 2018. Developmental cell. 44(5):634-641 . PubMed
  13. Philip E Boulais et al. 2018. Immunity. 49(4):627-639 . PubMed
  14. Breitbach M, et al. 2018. Cell Stem Cell. 1.098611111. PubMed
  15. Tadokoro Y, et al. 2018. Cell Stem Cell. 1.411805556. PubMed
  16. Hsu JI et al. 2018. Cell stem cell. 23(5):700-713 . PubMed
  17. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  18. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  19. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  20. Soukup AA, et al. 2019. J Clin Invest. 129:1180. PubMed
  21. Zhao M, et al. 2019. Cell Rep. 26:652. PubMed
  22. Stivala S, et al. 2019. J Clin Invest. 130:1596. PubMed
  23. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  24. Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
  25. Ise W, et al. 2018. Immunity. 48:702. PubMed
  26. Kobayashi H, et al. 2020. Cell Reports. 28(1):145-158.e9.. PubMed
  27. Zhou J, et al. 2019. Cell Stem Cell. 24:285. PubMed
  28. Seneviratne AK, et al. 2019. Cell Stem Cell. 24:621. PubMed
  29. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  30. Comazzetto S et al. 2018. Cell stem cell. 24(3):477-486 . PubMed
  31. Pierce H, et al. 2017. Cell Stem Cell. 1.283333333. PubMed
  32. Williams JW, et al. 2017. Circ Res. 121:662. PubMed
  33. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  34. van Oostrum M, et al. 2019. Nat Commun. 4.398611111. PubMed
  35. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  36. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  37. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  38. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  39. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  40. Baccelli I, et al. 2020. Cancer Cell. 36(1):84-99. PubMed
  41. He M, et al. 2020. Cell Metabolism. 31(3):580-591. PubMed
  42. Nacson J, et al. 2020. Molecular Cell. 78(5):951-959. PubMed
  43. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  44. Nagai M, et al. 2020. Cell. 178(5):1072-1087.e14.. PubMed
  45. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  46. Garaycoechea JI, et al. 2018. Nature. 553:171. PubMed
  47. Kobayashi H, et al. 2020. STAR Protoc. 1:100078. PubMed
  48. Kim I, et al. 2006. Blood. 108:737. PubMed
  49. Jung Y, et al. 2007. Blood . 110:82. PubMed
  50. Jordan M, et al. 2007. J Immunol. 178:1618. PubMed
  51. Fraser S, et al. 2007. Blood. 109:343. PubMed
  52. Jung Y, et al. 2008. Stem Cells. 26:2042. PubMed
  53. Morita Y, et al. 2010. J Exp Med. 207:1173. PubMed
  54. Song J, et al. 2010. Blood. 115:2592. PubMed
  55. Kaplan I, et al. 2011. J Immunol. 186:2826. PubMed
  56. Greenbaum A, et al. 2012. Blood. 120:295. PubMed
  57. Theocharides A, et al. 2012. J Exp Med. 209:1883. PubMed
  58. Jung Y, et al. 2011. Exp Hematol. 39:151. PubMed
  59. Chiba H, et al. 2013. Am J Physiol Cell Physiol. 305:693. PubMed
  60. Grassinger J, et al. 2012. Cytokine. 58:218. PubMed
  61. Du J, et al. 2012. Stem Cells. 30:1447. PubMed
  62. Maltby S, et al. 2014. J Immunol. 193:4072. PubMed
  63. Hu W, et al. 2015. Blood. 125:2206. PubMed
  64. Zhang J, et al. 2015. J Biol Chem. 290 19093 . PubMed
  65. Holzapfel B, et al. 2015. Biomaterials. 61: 103-114. PubMed
  66. Zhang J, et al. 2015. Leukemia. 29 1847 . PubMed
  67. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  68. Alvarez S, et al. 2015. Nat Commun. 6: 8548. PubMed
  69. Leiva M, et al. 2016. Nat Commun. 7:10222. PubMed
  70. Ley C, et al. 2015. Cancer Cell. 27: 631-43. PubMed
  71. Thongthip S, et al. 2016. Genes Dev. 30: 645 - 659. PubMed
  72. Pietras E, et al. 2016. Nat Cell Biol. 10.1038/ncb3346. PubMed
  73. Kokkaliaris K, et al. 2016. Blood. 128: 1181 - 1192. PubMed
  74. Bahal R, et al. 2016. Nat Commun. 7:13304. PubMed
  75. Asada N, et al. 2017. Nat Cell Biol. 19:214-223. PubMed
  76. Montecino-Rodriguez E, et al. 2020. STAR Protoc. 1:100159. PubMed
  77. Kang YA, et al. 2020. J Exp Med. 217:00:00. PubMed
  78. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  79. DeVilbiss AW, et al. 2021. eLife. 10:00. PubMed
  80. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  81. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  82. Nita A, et al. 2021. Cell Reports. 34(5):108688. PubMed
  83. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  84. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  85. Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed
  86. Chen Q, et al. 2019. Cell Stem Cell. 25(6):768-783.e6. PubMed
  87. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  88. Keerthivasan S, et al. 2021. Immunity. 54(7):1511-1526.e8. PubMed
  89. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  90. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  91. Kim SP, et al. 2021. Cell Reports. 36(9):109626. PubMed
  92. Xie M, et al. 2020. Haematologica. . PubMed
  93. Wei Q, et al. 2020. Dev Cell. 53:503. PubMed
  94. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  95. Wei Q, et al. 2021. Nat Commun. 12:2522. PubMed
  96. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  97. Dong S, et al. 2021. Nature. 591:117. PubMed
  98. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  99. Fujino T, et al. 2021. Nat Commun. 12:1826. PubMed
  100. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  101. Jia W, et al. 2021. Nat Commun. 12:2118. PubMed
  102. Yang L, et al. 2021. Front Immunol. 12:722273. PubMed
  103. Man N, et al. 2021. JCI Insight. 6:. PubMed
  104. Gao X, et al. 2021. Nature. 589:591. PubMed
  105. Fischer KC, et al. 2021. Cell Death Dis. 12:28. PubMed
  106. Ho TT, et al. 2021. J Exp Med. 218:. PubMed
  107. Soukup AA, et al. 2021. Sci Adv. 7:eabk3521. PubMed
  108. Li CC, et al. 2022. Nat Commun. 13:346. PubMed
  109. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  110. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  111. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  112. Sacma M, et al. 2022. STAR Protoc. 3:101483. PubMed
  113. Kinkel SA, et al. 2022. iScience. 25:104684. PubMed
  114. Pinho S, et al. 2022. Nat Cell Biol. 24:290. PubMed
  115. Yang S, et al. 2022. J Exp Med. 219:. PubMed
  116. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  117. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  118. Thomas GE, et al. 2022. Nat Cell Biol. 24:872. PubMed
  119. Jabbar S, et al. 2022. Exp Hematol Oncol. 11:83. PubMed
  120. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  121. Zhang D, et al. 2022. Cell Stem Cell. 29:232. PubMed
  122. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  123. Tátrai P, et al. 2022. EMBO J. 41:e108739. PubMed
  124. Xu Y, et al. 2023. EMBO Rep. 24:e55503. PubMed
  125. Huang D, et al. 2023. Exp Hematol Oncol. 12:11. PubMed
  126. Yuan O, et al. 2022. Sci Adv. 8:eabm9987. PubMed
  127. Meacham CE, et al. 2022. Nat Cell Biol. 24:697. PubMed
  128. Shiroshita K, et al. 2022. Cell Rep Methods. 2:100354. PubMed
  129. Kang YA, et al. 2023. J Exp Med. 220:. PubMed
  130. Meng Y, et al. 2023. Cell Mol Biol Lett. 28:45. PubMed
RRID
AB_313682 (BioLegend Cat. No. 115903)
AB_313683 (BioLegend Cat. No. 115904)

Antigen Details

Structure
Ig superfamily, 75-95 kD
Distribution

Thymocytes, T cell subset, B lymphocytes, dendritic cells, endothelial cells

Function
B cell and dendritic cell costimulation
Ligand/Receptor
CD150
Cell Type
B cells, Dendritic cells, Endothelial cells, T cells, Thymocytes, Tregs
Biology Area
Costimulatory Molecules, Immunology, Innate Immunity
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Cocks BG, et al. 1995. Nature 376:260.
2. Punnonen J, et al. 1997. J. Exp. Med. 185:993.
3. Sidorenko SP, et al. 1993. J. Immunol. 151:4614.

Gene ID
27218 View all products for this Gene ID
UniProt
View information about CD150 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 1    Revision Date: 11/30/2012

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account